Dendrite Announces Fourth Quarter 2006 Earnings Conference Call

  
    
  
  
    
      Dendrite International, Inc. (NASDAQ: DRTE) a leading provider of 
      pharmaceutical industry solutions, today announced that it plans to 
      release its fourth quarter earnings after the close of market on 
      Thursday, February 15, 2007. A press release will be issued at 4 p.m. 
      EST that day, followed by a conference call at 5 p.m. EST.
    
    
      Information on how to access a live simulcast or replay of the call via 
      webcast or telephone can be found by visiting the Investors' 
      Highlights section of www.dendrite.com.
    
    
      About Dendrite
    
    
      Founded in 1986, Dendrite International (NASDAQ: DRTE) enables sales, 
      marketing, clinical and compliance solutions for the global 
      pharmaceutical industry. The Company’s clients 
      are located in more than 50 countries, and include the world's top 20 
      pharmaceutical companies. For more information, please visit www.dendrite.com.
    
    
      Note: Dendrite is a registered trademark of Dendrite International, Inc.
    
    
      FORWARD LOOKING INFORMATION: This document contains forward-looking 
      statements that may be identified by such forward-looking terminology as 
      "expect," "believe," "anticipate," "will," "intend," "plan," "target," 
      "outlook," "guidance," and similar statements or variations. All of our 
      "outlook" information constitutes forward looking statements. Such 
      forward-looking statements are based on our current expectations, 
      estimates, assumptions and projections and involve significant risks and 
      uncertainties, including risks associated with estimating and planning 
      for (i) revenues based on customer decisions and (ii)unanticipated and 
      unplanned for events over a 12 month or more period; risks which may 
      result from our dependence on the pharmaceutical industry; our fixed 
      expenses in relation to fluctuating revenues and variations in 
      customers' budget cycles; dependence on certain major customers, 
      including the risk associated with our largest customer's plans to 
      transition a significant portion of its U.S. sales force effectiveness 
      services needs; fluctuations in quarterly revenues due to lengthy sales 
      and implementation cycles; the success of our Operational Effectiveness 
      program and ability to achieve the cost savings in the amounts and time 
      periods expected and budgeted; changes in demand for our products and 
      services attributable to any weakness experienced in the economy or 
      mergers, acquisitions and consolidations in the pharmaceutical industry; 
      risks associated with foreign currency fluctuations as they affect our 
      non-U.S. operations; risks associated with our expanded international 
      operations and our ability to adopt and respond successfully to the 
      unique risks involved in our non-U.S. operations; any difference between 
      estimated and actual stock option expense; and risks associated with 
      reviewing and considering strategic options, as previously announced, 
      and with any transaction occurring or being consummated at any 
      subsequent time. Other important factors that should be reviewed and 
      carefully considered are included in the Company's 10-K under "Factors 
      That May Affect Future Results" and its 10-Qs and other reports filed 
      with the SEC. Actual results may differ materially. The Company assumes 
      no obligation for updating, and does not plan or undertake to update, 
      any such forward-looking statements to reflect actual results, changes 
      in expectations or assumptions or other changes affecting such 
      forward-looking statements, even if such results or changes make it 
      clear that any such projected results will not be achieved. Any outlook 
      and other forward-looking information is as of the date of this release 
      only. At any such time in the future as the Company may provide revenue, 
      earnings and other outlook information, prior related outlook should no 
      longer be considered current. Our outlook and other forward-looking 
      information do not take into account or reflect any possible future 
      acquisitions, dispositions or similar transactions which may occur.